The Sahajanand Medical Technologies IPO officially opened for public bidding in the IPO market today as Sahajanand Medical Technologies Ltd launched its public offering on the BSE and NSE mainboards. Recognized as a flagship latest Mainboard IPO, the Sahajanand Medical Technologies IPO brings India’s leading indigenous cardiovascular device and medical stent innovator to public bourses, with Sahajanand Medical Technologies floating a book-built issue of ₹475.48 crore through a 100% Offer for Sale (OFS). Priced at a Mainboard IPO issue price band of ₹327 to ₹344 per share, tracking IPO updates today reveals that institutional allocators and retail participants are closely evaluating the Sahajanand Medical Technologies IPO order velocity.
What the Grey Market Is Signaling
Unlisted dealing desks tracking the IPO grey market today report steady and optimistic sentiment for the Sahajanand Medical Technologies IPO. The Sahajanand Medical Technologies IPO GMP live quotes at a solid premium of +₹41 to +₹46 per share over the upper price band of ₹344. Evaluating the Mainboard IPO GMP today, the expected IPO listing gain for the Sahajanand Medical Technologies IPO is projected between 11.92% and 13.37%, pointing to an indicative listing print near ₹385 to ₹390. Rather than speculative froth, this stable IPO grey market premium indicates that participants across latest IPO GMP channels are pricing in the dominant domestic market share of Sahajanand Medical Technologies Ltd in drug-eluting stents (DES). This firm trend reflects durable pre-issue institutional confidence in Sahajanand Medical Technologies.
Subscription Numbers Back the Hype: Day 1 Live Demand
Ahead of the closing of Day 1 bidding, syndicate desks report solid engagement across the Sahajanand Medical Technologies IPO order books:
- Net Offer Allocation: Out of the net public offer for Sahajanand Medical Technologies, not more than 50% is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for Retail Bidders.
- Retail Lot Commitment: A single retail application for the Sahajanand Medical Technologies IPO requires a minimum lot size of 43 shares, amounting to an accessible capital outlay of ₹14,792 at the cap price.
- Day 1 Bidding Progress: By the close of Day 1, the Sahajanand Medical Technologies Mainboard IPO subscription status recorded an overall subscription of 0.35x, led by retail investors who subscribed 0.41x of their allocated quota and NIIs at 0.33x, while institutional books in the Sahajanand Medical Technologies IPO are positioned to build further traction on the closing days.
Why the Market Is Bullish on This Mainboard IPO
Key operational moats highlighted in the Sahajanand Medical Technologies Mainboard IPO details include:
- Cardiovascular Stent & TAVI Moat: Sahajanand Medical Technologies commands nearly 25% market share by sales volume in India's drug-eluting stent (DES) segment, alongside an expanding footprint in structural heart solutions like Transcatheter Aortic Valve Implantation (TAVI).
- Global Footprint & Production Scale: Sahajanand Medical Technologies Ltd markets life-saving medical devices across 77 countries, supported by three advanced manufacturing facilities in Surat, Hyderabad, and Thailand, alongside dedicated global R&D centres.
- Financial Expansion & Turnaround: In FY26, consolidated revenues for Sahajanand Medical Technologies crossed ₹1,210 crore, with operating EBITDA reaching ₹170.65 crore and net earnings demonstrating a positive operational turnaround.
- Defensible Intellectual Property: Holding over 119 granted patents globally, Sahajanand Medical Technologies Ltd commands a post-issue market capitalization of ₹3,496.65 crore at the upper band, pricing the company competitively relative to global med-tech players.
Important Caveats for Grey Market Watchers
Before tracking the Sahajanand Medical Technologies Mainboard IPO GMP, keep these risk factors in view:
- 100% OFS Structure: The offering is entirely an Offer for Sale of 1.38 crore equity shares; Sahajanand Medical Technologies Ltd receives zero fresh proceeds on its corporate balance sheet from the Sahajanand Medical Technologies IPO.
- Supplier Concentration: The manufacturing operations of Sahajanand Medical Technologies depend on specialized global suppliers for critical raw materials and stent components without long-term binding supply agreements.
- Unregulated Trading & Discovery: Dealing in the Sahajanand Medical Technologies IPO grey market operates informally without SEBI or stock exchange settlement guarantees, and final listing gains depend strictly on official exchange order matching when the stock debuts on the Mainboard IPO list.
The Bottom Line: Mainboard IPO Listing Date & Schedule
The Sahajanand Medical Technologies IPO provides investors with direct exposure to India's high-barrier medical technology and cardiovascular devices sector. With the Mainboard IPO GMP today indicating positive momentum, primary desks are monitoring the scheduled timetable for the Sahajanand Medical Technologies IPO:
- Public Bidding Opens: Thursday, October 15, 2026 (Today)
- Public Bidding Closes: Monday, October 19, 2026 (5:00 PM UPI cutoff)
- Basis of Allotment: Wednesday, October 21, 2026, for the Sahajanand Medical Technologies IPO, verifiable via MUFG Intime India Pvt. Ltd.
- Mainboard IPO Listing Date: Friday, October 23, 2026, on BSE and NSE for Sahajanand Medical Technologies